BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
31 hedge funds and large institutions have $5.58M invested in Baudax Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
41% less capital invested
Capital invested by funds: $9.43M → $5.58M (-$3.85M)
Holders
31
Holding in Top 10
–
Calls
$361K
Puts
$17K
Top Buyers
| 1 | +$274K | |
| 2 | +$216K | |
| 3 | +$115K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$94.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$36.1K |
Top Sellers
| 1 | -$294K | |
| 2 | -$282K | |
| 3 | -$239K | |
| 4 |
Bank of New York Mellon
New York
|
-$131K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$122K |